A research team led by Professor Jung Se-young of the Department of Family Medicine at Seoul National University Bundang ...

Hanmi Pharmaceutical's first domestically developed GLP-1 obesity drug has won regulatory approval in Korea, setting up ...

With its second oligonucleotide manufacturing plant now in full operation, ST Pharm is using CPHI Worldwide 2026 in Milan, ...

Korean pharmaceutical and biotechnology companies will present cancer drug development data at ESMO Congress 2026 in Madrid ...

Nearly three-quarters of foreign patient visits to medical departments in Korea last year were for dermatology or plastic ...

CG MedTech has secured regulatory approval in Colombia for its INNOVERSE Spinal System and plans to introduce the spinal ...

Korean biotech PRG S&Tech has begun enrolling patients in a U.S. phase 2 clinical trial of Progerinin, an experimental ...

HanAll Biopharma has expanded its hair loss treatment portfolio with the launch of Pangro Solution 5%, an over-the-counter ...

Despite major advances in psoriasis treatment, many Korean patients remain undertreated and face social stigma, prompting ...

GI Innovation said Wednesday that its Japanese partner Maruho plans to dose the first patient in a phase 2 trial of allergy ...

A police raid on Ajou University Hospital’s pediatric emergency center drew scrutiny at a parliamentary audit Wednesday, ...

Less than two weeks after winning U.S. approval for lirafugratinib, HLB is moving the targeted bile duct cancer drug through ...